Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis
ACS Nano · 21.01.2025 · 19 (2) · 2742-2758
DOI: 10.1021/acsnano.4c15130 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 10.01.2025. Verfasst von Shengting Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Small Interfering, Interleukin-11, Pulmonary Fibrosis. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Xiamen Municipality, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
- Institute of Functional Nano and Soft Materials, Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.
- College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.
- Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Central Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
- School of Materials Science and Engineering, Tongji University, Shanghai 201804, China.
ORCID-Profile: Huapan Fang, Qian Chen, Yang Yang
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Xiamen Municipality
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Program of Shanghai Academic Research Leader
- Shanghai Municipal Key Clinical Specialty
Zitieren
APA
Dong, S., Fang, H., Zhu, J., Wu, Z., Liu, Y., Zhu, J., Ma, B., Chen, Q., & Yang, Y. (2025). Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis. ACS Nano, 19(2), 2742-2758. https://doi.org/10.1021/acsnano.4c15130
Vancouver
Dong S, Fang H, Zhu J, Wu Z, Liu Y, Zhu J, et al. Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis. ACS Nano. 2025;19(2):2742-2758. doi:10.1021/acsnano.4c15130
BibTeX
@article{Dong2025,
author = {Dong, Shengting and Fang, Huapan and Zhu, Junjie and Wu, Zhiqiang and Liu, Yi and Zhu, Jiafei and Ma, Benting and Chen, Qian and Yang, Yang},
title = {Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {2},
pages = {2742--2758},
doi = {10.1021/acsnano.4c15130}
}
EUVIMED